This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Burton, M. A. Articles by Townsend, P. S. Search for Related Content PubMed PubMed Citation Articles by Burton, M. A. Articles by Townsend, P. S.

Manipulation of Experimental Rat and Rabbit Liver Tumor Blood Flow with Angiotensin II¹

Departments of Surgery [M. A. B., B. N. G., G. W. S., P. S. T.] and Physical Sciences [J. C. H.], University of Melbourne, St. Vincent's Hospital, Fitzroy 3065, Australia

The effects of angiotensin II on the distribution of blood flow to experimental hepatic tumors in ten rats and rabbits were examined using blood flow tracer microspheres. The ratio of arterially introduced microspheres lodging in tumor tissue compared to the surrounding normal hepatic parenchyma was measured before and after i.v. infusion of angiotensin II-inducing incremental systemic responses. A significant elevation (P < 0.05) in this ratio was described for both rats (3.0-fold) and rabbits (3.2-fold) following the drug infusion. Ratio elevation occurred in 37 of 40 tumors examined despite the lack of a clear dose-response relationship. In addition, angiotensin II was found to significantly (p < 0.05) increase the number of microspheres gaining arterial access to the central portions of the tumors. In terms of internal radiation therapy, these results would indicate a substantially enhanced radiation dose reaching tumor tissue after angiotensin II infusion, while relatively sparing the surrounding normal tissue.

¹ Supported by the facilities of St. Vincent's Hospital, Experimental Medical and Surgical Department.

² To whom requests for reprints should be addressed, at University Department of Surgery, Royal Perth Hospital, Perth, WA, 6000, Australia.

Received 11/20/84. Revised 5/ 6/85. Accepted 7/18/85.

This article has been cited by other articles:

				S. M. Galbraith, R. J. Maxwell, M. A. Lodge, G. M. Tozer, J. Wilson, N. J. Taylor, J. J. Stirling, L. Sena, A. R. Padhani, and G. J.S. Rustin Combretastatin A4 Phosphate Has Tumor Antivascular Activity in Rat and Man as Demonstrated by Dynamic Magnetic Resonance Imaging J. Clin. Oncol., August 1, 2003; 21(15): 2831 - 2842. [Abstract] [Full Text] [PDF]